| Sequent Scientific Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 512529 |
NSE Symbol : SEQUENT |
P/E(TTM) : 345.41 |
|
ISIN Demat : INE807F01027 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.61 |
|
Book Value(₹) : 46.50 |
Market Cap(₹Cr) : 5,354.15 |
Face Value(₹) : 2.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 34.03 | 41.07 | 42.33 | 36.27 | 41.99 | 57.67 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 34.03 | 41.07 | 42.33 | 36.27 | 41.99 | 57.67 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 11.75 | 11.48 | 12.27 | 11.88 | 15.95 | 10.84 |
| Total Income | 45.78 | 52.55 | 54.60 | 48.15 | 57.94 | 68.51 |
| Total Expenditure | 38.37 | 44.36 | 45.40 | 41.06 | 48.41 | 59.65 |
| PBIDT | 7.41 | 8.19 | 9.20 | 7.09 | 9.53 | 8.86 |
| Interest | 0.83 | 1.08 | 0.99 | 1.17 | 1.00 | 0.81 |
| PBDT | 6.58 | 7.11 | 8.21 | 5.92 | 8.53 | 8.05 |
| Depreciation | 2.24 | 2.33 | 2.30 | 2.24 | 2.12 | 2.00 |
| Tax | 2.25 | 0.84 | 1.11 | 0.73 | 1.07 | 0.97 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.99 | 0.57 | 0.57 | 0.14 | 1.08 | 0.58 |
| Reported Profit After Tax | 3.08 | 3.37 | 4.23 | 2.81 | 4.26 | 4.50 |
| Extra-ordinary Items | -0.82 | -0.88 | -0.18 | -0.24 | -2.87 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 3.90 | 4.25 | 4.41 | 3.05 | 7.13 | 4.50 |
| EPS (Unit Curr.) | 0.12 | 0.14 | 0.17 | 0.11 | 0.17 | 0.18 |
| EPS (Adj) (Unit Curr.) | 0.12 | 0.14 | 0.17 | 0.11 | 0.17 | 0.18 |
| Calculated EPS (Unit Curr.) | 0.12 | 0.13 | 0.17 | 0.11 | 0.17 | 0.18 |
| Calculated EPS (Adj) (Unit Curr.) | 0.12 | 0.13 | 0.17 | 0.11 | 0.17 | 0.18 |
| Calculated EPS (Ann.) (Unit Curr.) | 0.49 | 0.54 | 0.68 | 0.45 | 0.68 | 0.72 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 0.49 | 0.54 | 0.68 | 0.45 | 0.68 | 0.72 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 50.33 | 50.07 | 50.06 | 50.06 | 49.92 | 49.90 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 21.77 | 19.94 | 21.73 | 19.55 | 22.70 | 15.36 |
| PBDTM(%) | 19.34 | 17.31 | 19.40 | 16.32 | 20.31 | 13.96 |
| PATM(%) | 9.05 | 8.21 | 9.99 | 7.75 | 10.15 | 7.80 |